相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis
Rulin Zhuang et al.
OBESITY REVIEWS (2019)
Plasma level of peroxiredoxin 3 in patients with polycystic ovarian syndrome
Hou-Li Liu et al.
BMC ENDOCRINE DISORDERS (2019)
Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes - a cross-sectional study
Monica Gupta et al.
GYNECOLOGICAL ENDOCRINOLOGY (2019)
Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?
Milica Popovic et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome
Xinyu Qi et al.
NATURE MEDICINE (2019)
Insulin resistance and NAFLD: Relationship with intrahepatic iron and serum TNF-α using 1H MR spectroscopy and MRI
J. L. Martin-Rodriguez et al.
DIABETES & METABOLISM (2019)
Saturated Fat Ingestion Promotes Lipopolysaccharide-Mediated Inflammation and Insulin Resistance in Polycystic Ovary Syndrome
Frank Gonzalez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Profiles for long non-coding RNAs in ovarian granulosa cells from women with PCOS with or without hyperandrogenism
Li Jin et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2018)
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis
Gabriele Giacomo Schiattarella et al.
EUROPEAN HEART JOURNAL (2017)
Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD
Mohammed A. I. Al-Obaide et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer
Jens Oellgaard et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Effects of Interleukin 17 on the cardiovascular system
Marie Robert et al.
AUTOIMMUNITY REVIEWS (2017)
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Weifei Zhu et al.
CELL (2016)
Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels
M. Dambrova et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2016)
Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome
Asli Nehir Aytan et al.
GYNECOLOGICAL ENDOCRINOLOGY (2016)
Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome
M. Karakose et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
Ji Miao et al.
NATURE COMMUNICATIONS (2015)
Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation
Dongmei Zhang et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Serum tumor necrosis factor-α, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, pcos, or unexplained infertility
Abdelmoneim Younis et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2014)
Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review
Xinghua Xu et al.
BMC WOMENS HEALTH (2014)
Prevalence of polycystic ovary syndrome in women in China: a large community-based study
Rong Li et al.
HUMAN REPRODUCTION (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
Mediators of chronic inflammation in polycystic ovarian syndrome
E. Deligeoroglou et al.
GYNECOLOGICAL ENDOCRINOLOGY (2012)
Diversity, stability and resilience of the human gut microbiota
Catherine A. Lozupone et al.
NATURE (2012)
Dysbiosis of Gut Microbiota (DOGMA) - A novel theory for the development of Polycystic Ovarian Syndrome
Kelton Tremellen et al.
MEDICAL HYPOTHESES (2012)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Is interleukin-18 associated with polycystic ovary syndrome?
Yan Yang et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2011)
Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors
Cemil Kaya et al.
FERTILITY AND STERILITY (2010)
Proteomic Analysis of Plasma in the Polycystic Ovary Syndrome Identifies Novel Markers Involved in Iron Metabolism, Acute-Phase Response, and Inflammation
Maria Insenser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment
Suzanne M. de la Monte et al.
MOLECULAR NEURODEGENERATION (2009)
Nontraditional risk factors for cardiovascular disease in diabetes
V Fonseca et al.
ENDOCRINE REVIEWS (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
分享论文
